Arcturus Therapeutics Holdings Inc.
ARCT
$12.91
$0.020.16%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -30.01M | -6.90M | -17.22M | -26.82M | -11.71M |
| Total Depreciation and Amortization | 819.00K | 912.00K | 909.00K | 904.00K | 815.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.81M | 9.70M | 9.81M | 10.14M | 8.82M |
| Change in Net Operating Assets | 20.09M | -27.47M | -23.65M | 10.22M | 1.45M |
| Cash from Operations | -284.00K | -23.76M | -30.14M | -5.56M | -629.00K |
| Capital Expenditure | 0.00 | -80.00K | -328.00K | -240.00K | -875.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -80.00K | -328.00K | -240.00K | -875.00K |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -20.00M |
| Issuance of Common Stock | 134.00K | 693.00K | 2.40M | 2.19M | 1.34M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 134.00K | 693.00K | 2.40M | 2.19M | -18.66M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -150.00K | -23.15M | -28.07M | -3.61M | -20.16M |